Who are Benzathine penicillin G's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Amoxil, Bicillin C-R, Bicillin C-R, Antibiotics, cefuroxime and metronidazole, piperacillin continuous infusion, Piperacillin, Tazobactam Drug Combination.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/benzathine-penicillin-g.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Benzathine penicillin G — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Benzathine penicillin G (Benzathine penicillin G) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Beta-lactam antibiotic. Area: Infectious Disease.

marketed Beta-lactam antibiotic Penicillin-binding proteins (PBPs) Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Benzathine penicillin G (Benzathine penicillin G) — International Maternal Pediatric Adolescent AIDS Clinical Trials Group. Benzathine penicillin G inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and blocking peptidoglycan cross-linking.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Benzathine penicillin G TARGET	Benzathine penicillin G	International Maternal Pediatric Adolescent AIDS Clinical Trials Group	marketed	Beta-lactam antibiotic	Penicillin-binding proteins (PBPs)
Amoxil	amoxicillin	Generic (originally Beecham/GSK)	marketed	Aminopenicillin (Beta-lactam antibiotic)	5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2C	1972-01-01
Bicillin C-R	Penicillin G Benzathine	Pfizer	marketed	Beta-lactam antibiotic	Cell-wall peptidoglycan biosynthesis	1952-01-01
Bicillin C-R	Penicillin G Benzathine	Pfizer	marketed	Beta-lactam antibiotic	Cell-wall peptidoglycan biosynthesis	1952-01-01
Antibiotics, cefuroxime and metronidazole	Antibiotics, cefuroxime and metronidazole	Helsinki University Central Hospital	marketed	Beta-lactam antibiotic + nitroimidazole antibiotic combination	Bacterial penicillin-binding proteins (cefuroxime); anaerobic bacterial DNA (metronidazole)
piperacillin continuous infusion	piperacillin continuous infusion	University Hospital, Ghent	marketed	Beta-lactam antibiotic (ureidopenicillin)	Penicillin-binding proteins (PBPs)
Piperacillin, Tazobactam Drug Combination	Piperacillin, Tazobactam Drug Combination	Phoenix Children's Hospital	marketed	Beta-lactam antibiotic with beta-lactamase inhibitor	Penicillin-binding proteins (PBPs); beta-lactamase enzymes

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2026-12-08 — Amoxil · 8778924 · Compound · US
2026-12-08 — Amoxil · 8357394 · Formulation · US
2027-05-07 — Amoxil · 8299052 · Method of Use · US

Sponsor landscape (Beta-lactam antibiotic class)

Pfizer · 2 drugs in this class
Bayer · 1 drug in this class
Belén Retamal-Valdes · 1 drug in this class
Benova (Tianjin) Innovative medicine Research Co., Ltd. · 1 drug in this class
Esraa Salah Mohamed Abdallah Eladl · 1 drug in this class
Incheon St.Mary's Hospital · 1 drug in this class
International Maternal Pediatric Adolescent AIDS Clinical Trials Group · 1 drug in this class
KEMRI-Wellcome Trust Collaborative Research Program · 1 drug in this class
National Taiwan University Hospital · 1 drug in this class
Pfizer Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Benzathine penicillin G — Competitive Intelligence Brief. https://druglandscape.com/ci/benzathine-penicillin-g. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab